Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-21

Clinical Trial Update: A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effect of 6R-BH4 on blood pressure in subjects with poorly controlled systemic hypertension has completed. The sponsor is BioMari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 6R-BH4 (6R-tetrahydrobiopterin)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Hypertension | Phase 2 | Status: COMPLETED